Caricamento...
Diphtheria toxin‐based anti‐human CD19 immunotoxin for targeting human CD19(+) tumors
CD19 is expressed on normal and neoplastic B cells and is a promising target for immunotherapy. However, there is still an unmet need to further develop novel therapeutic drugs for the treatment of the refractory/relapsing human CD19(+) tumors. We have developed a diphtheria toxin‐based anti‐human C...
Salvato in:
| Pubblicato in: | Mol Oncol |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5527461/ https://ncbi.nlm.nih.gov/pubmed/28306193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12056 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|